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CSb-9 increases albumin permeability of isolated glomeruli in vitro.
Deposition of antibody and activation of the complement cascade are
important in both naturally occurring glomerulonephritis and in experi-
mental models including passive Heymann nephritis. We studied the effect
of antibody and complement on albumin permeability of isolated glomer-
nh to determine the role of the terminal complement components (C5-C9)
in mediating the proteinuria in nephritis. Isolated glomeruli were treated
with anti-Fxla (Heymann antibody) and then incubated them with pooled
human serum, serum in which complement had been inactivated by heat,
or serum deficient in C6 or C7. The albumin reflection coefficient
(oarnmjn) was calculated from the volumetric response of glomeruli to
transcapillary oncotic gradients produced by albumin or high molecular
weight neutral dextran (252 kD). Convectional permeability to albumin
(Palbumin) was calculated as 1— aIbumin Albumin permeability of control
glomeruli was not different from 0. Albumin permeability was not altered
by antibody alone but was increased to 0.65 0.04 when antibody treated
glomeruli were incubated for 10 minutes with pooled serum as a source of
complement. Heat treatment of serum to inactivate complement pre-
vented the increase in permeability. Incubation for 10 minutes with serum
without antibody pretreatment caused a lesser increase in permeability of
isolated glomeruli (0.18 0.06). Serum deficient in either C6 or C7 did
not cause an increase in albumin permeability of antibody pre-treated
glomeruli, but incubation with a combination of these sera (now contain-
ing the complete cascade) increased permeability to the same extent as did
pooled normal serum (0.58 0.04). We conclude that activation of the
terminal complement components is required for the increase in glomer-
ular macromolecular permeability caused by anti-Fxla and that terminal
complement activation is sufficient to alter the permeability independent
of complement hemodynamic events or contribution by circulating cells.
Membranous nephropathy (MN) is a unique glomerular lesion
characterized by diffuse deposition of IgG and complement in an
exclusively subepithelial distribution [1]. These deposits induce a
marked alteration in glomerular barrier function in the absence of
any detectable inflammatosy cell infiltrate [1]. In rats, a lesion
indistinguishable from MN can be induced by active or passive
immunization to a crude kidney brush border membrane fraction
termed Fxla (Heymann nephritis) [reviewed in 2]. Several studies
over the past decade have shown that the subepithelial deposition
of IgG in experimental MN results from the direct binding of
antibody to antigen(s) expressed in the clathrin-coated pits along
the membrane of glomerular epithelial cell (GEC) podocytes
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[reviewed in 2]. It is now well established that this proteinuria is
mediated by the C5b-9 membrane attack complex of complement.
This hypothesis has been confirmed by studies of selective C6
depletion in two models of MN in the intact rat [3, 4], of
congenital C6 deficiency in a chronic serum sickness model of MN
in the rabbit [5], and of the requirement for C6 and C8 in the
induction of proteinuria by anti-Fxla IgG in the isolated perfused
rat kidney [6].
While these studies provide strong evidence for a nephritogenic
role for C5b-9 in mediating the injury induced by subepithelial
immune complex deposits in several systems, analysis of the
mechanism of this C5b-9 effect has been restricted by the limita-
tions inherent in studying cellular events in a whole animal or
whole organ system. Attempts to explore this issue by studying
sublytic effects of antibody and C5b-9 on GEC in culture have
yielded a substantial body of data demonstrating that C5b-9
results in increased intracellular calcium, activation of phospho-
lipase C, increased levels of 1P2, 1P3, diacyl glycerol and phos-
phatidic acid with release of arachidonic acid, PGF2 and throm-
boxane [7—9]. However, there is currently no way to directly link
these abnormalities induced by sublytic C5b-9 in cell culture with
effects on glomerular permeability to protein in the intact glomer-
ulus.
In the present study, we provide data on the effects of anti-Fx1A
antibody and C5b-9 attack on the permeability barrier of the
isolated normal rat glomerulus. This in vitro system permitted us
to measure the albumin reflection coefficient (O•albumin) directly.
The results confirm that C5b-9 plays an essential role in mediating
injury induced by anti-Fx1A antibody and demonstrate that this
effect occurs immediately. In addition, the data established that
studies of albumin permeability of isolated glomeruli in vitro can
be used to define the effects of individual inflammatory mediators
on the integrity of the glomerular barrier to albumin.
Methods
Glomerular isolation and measurement of capillary volume
response to oncotic gradients
Glomeruli were isolated from the renal cortex of adult Sprague-
Dawley rats (180 to 250 g body wt) using standard sieving
techniques [10]. Isolation medium contained (in mmole/liter):
sodium chloride, 115; potassium chloride, 5; sodium acetate, 10;
dibasic sodium phosphate, 1.2; sodium bicarbonate, 25; magne-
sium sulfate, 1.2; calcium chloride, 1.0; and glucose, 5.5. The
oncotic content of the medium was varied by the addition of
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bovine serum albumin (BSA), 1, 4, 6, 8 gIdl, (oncotic pressure, 2.3,
17.5, 24.8 or 37.7 mm Hg, respectively) or of high molecular
weight neutral dextran, 252 kD, 1, 4, 6, 8 g/dl (oncotic pressure
3.25, 18.2, or 39.4 mm Hg). BSA was chosen because albumin is
the molecule of interest in relation to glomerular injury and
because it provides a sensitive probe for changes in the perme-
ability barrier of the glomerular capillary. Neutral dextran of high
molecular weight was chosen because data from sieving experi-
ments indicate that the glomerular capillary remains impermeant
to molecules of this size in both normal and proteinuric rats [11,
12] and in proteinuric humans [131. The oncotic pressure of the
media was measured using a membrane oncometer (Wescor, Inc.,
Model 4100, Logan, Utah, USA). The membrane used had a
molecular weight cut-off of 30 kD (Amicon PM 30, Amicon
Division, W.R. Grace and Co., Beverly, Massachusetts, USA).
The volume response of the glomerular capillary volume to
oncotic pressure gradients was examined in the following manner.
Glomeruli were observed using videomicroscopy and glomerular
volume was calculated from the average diameter measured from
the video monitor. After an initial period of observation, the
medium was replaced by fresh medium of different oncotic
composition. Volume changes consequent to this alteration in
medium composition occurred within five seconds and were
maintained for at least several minutes in both control and
experimental glomeruli. 0albumin was calculated from the glomer-
ular volumes measured prior to and 30 seconds after medium
exchange.
Measurement of albumin reflection coefficient and convectional
permeability
The rationale and calculations for these measurements have
been detailed elsewhere [14]. The following equation was used for
the calculation of reflection coefficients:
= L1D (L7so1uteTsolute).
This equation is valid when the arteriolar fragments are patent so
there is no significant transcapillary hydrostatic pressure gradient. In
this case, equilibrium, defined as Jv = 0, occurs when there is no
significant oncotic gradient, that iS( TsoiuteTiute) = 0 [14].
The response to iso-oncotic medium change was used to
determine whether °albumin was less than 1.0. Glomeruli were
isolated in 4 g/dl BSA medium and glomerular volume was
measured. The bathing medium was then replaced with an
albumin-free solution of neutral dextran of the same osmolality,
lTdextran = albumin initial mediumS Following this exchange, equilib-
rium was rapidly re-established by movement of fluid across the
glomerular capillaries. The new glomerular volume was stable
within five seconds and remained unchanged for several minutes.
If very little plasma protein was lost, it follows that
albumhi = (Vcapiiiaayfinal/Vcapillaiy initial).
If albumin is equal to Udextran which is 1.0 for the large molecule
used in these studies, the exchange of BSA medium for neutral
dextran medium of the same oncotic pressure will not result in any
net fluid flux or change in capillary volume. In contrast, j1 l7albumin
is less than 1, capillary volume will decrease and equilibrium will
occur at a diminished capillary and glomerular volume.
In selected conditions, volume responses to sequential changes
of medium in which BSA or dextran was used to vary the oncotic
pressure were used to calculate 0albumin The magnitude of the
increase in glomerular volume following changes in bathing media
depends on the physical properties of the glomerulus as well as on
the permeability characteristics of the filtration barrier. There is a
direct relationship between the increase in glomerular volume and
the oncotic gradient applied across the capillary wall for both
normal glomeruli and those in which permeability has been
increased by incubation with protamine [12, 13]. In selected
experiments, glomeruli were isolated in media with albumin
concentrations up to 8 g/dl (38 mm Hg) or high molecular weight
neutral dextran concentration of up to 6 g/dl (39 mm Hg).
Medium was replaced in step-wise fashion by solutions with lower
concentrations of the same solute. Volume response was
measured after 30 seconds. Since AV is proportional to
(Osoiute7Tsoiute), and if dextran = 1,
albumin =
albumin for glomeruli in each experimental condition was
calculated using the ratio of zW of experimental and control
glomeruli exposed to identical gradients of BSA. In this case, we
first determined that the volume responses of control and exper-
imental glomeruli to neutral dextran were also the same, that is,
Udextran = 1.0. In these experiments, 0albumin was calculated as:
(obumin)experimental = (Va1bumin)experimental/(Va1bumin)controI. [14]
Convectional permeability
Convectional permeability was defined as COnvectional (1 —
albumin). This parameter describes the movement of albumin
consequent to water flow and is distinct from diffusional perme-
ability which is independent of solvent movement.
Induction of glomerular injury
The C5b-9 injury was induced by sensitizing freshly isolated rat
glomeruli with sheep anti-Fx1A IgG and then exposing them to
dilutions of fresh human serum as a complement source. Concen-
trations of anti-Fx1A IgG and human serum were chosen to
induce sublytic C5b-9 injury. Anti-Fx1A IgG and normal sheep
IgG were prepared from whole sheep serum or anti-serum as
described in detail elsewhere [15, 16]. The same reagent has been
utilized to induce proteinuria in the intact animal [15]. To
determine an optimal concentration of antibody for use in these
studies, rat GEC cultured as described elsewhere [17, 18] were
incubated with anti-Fx1A IgG in concentrations from 0.5 to 10
mg/ml in cold verona! buffered saline at 4°C for 15 minutes. LDH
release into the medium was measured using a colorimetric test
kit (LDH-LD, Sigma Chemical Co., St. Louis, USA). Concentra-
tions of less than 5 mg/ml were found not to cause cytotoxicity as
documented by LDH release of less than 5% and Trypan blue
exclusion of >95% [18]. A concentration of 4 mg/ml was utilized
for the studies with isolated glomeruli. Similarly, GEC in culture
were treated first with anti-Fx1A IgG (4 mg/mI) prior to incuba-
tion with dilutions of fresh, pooled human serum in verona!
buffered saline as a complement source at 37°C for 30 minutes. A
concentration of 2% vol/vol was found to be sublytic as defined by
producing <5% LDH release and >95% Tiypan blue exclusion.
Therefore, a 2% dilution of fresh human serum was used for the
studies of isolated glomeruli.
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For studies of albumin permeability, a suspension of freshly
isolated normal rat glomeruli was incubated first with anti-Fx1A
IgG or normal sheep IgG at a concentration of 4 mg/ml in 5 ml of
isolation medium at 4°C for 15 minutes followed by two washes in
isolation medium at 4°C and then incubation with 2% fresh or
heat-inactivated (56°C, 30 mm) pooled human serum at 37°C for
15 minutes. The glomeruli were then exposed to oncotic gradients
for permeability measurements. In some experiments, normal
human serum was replaced with sera from patients known to be
genetically deficient in C6 and C7 or in serum made from a 1:1
mixture of these two complement-deficient sera.
To determine whether the injury consequent to antibody and
complement was related to cell lysis in intact glomeruli that did
not occur in cultured cells, LDH release was measured in suspen-
sions of isolated glomeruli using a commercially available kit
(Sigma, DG134OK-UV). Three independent experiments were
performed. LDH was measured after control incubation without
serum or after pretreatment with anti-Fx1A and incubation in
serum free medium or medium containing 2% vol/vol serum as a
source of complement. LDH activity averaged 100 38 smol/
liter/min/1000 glomeruli after control incubation. LDH was not
increased significantly by pretreatment with anti-Fx1A followed
by incubation in serum-free medium or in medium with serum,
averaging 100 47 and 99 35, respectively. In contrast, LDH
after treatment with lysing buffer was 1500 445 imol/liter/min/
1000 glomeruli (P < 0,001 vs. other groups, one way ANOVA).
Statistics
All values are expressed as mean SD unless stated otherwise.
Statistical significance (defined as P < 0.05) was evaluated using
the Student's t-test on one way analysis of variance with modified
t-tests performed using the Bonferroni correction.
Results
Effect of anti-FxJA and complement on 0'albu,,ün
Diminished 0'albumin was definitively documented in glomeruli
isolated and incubated in medium containing 4 gJdl BSA, treated
with anti-Fxla and complement, and then washed with iso-oncotic
high molecular weight neutral dextran as an impermeant solute.
Every glomerulus immediately lost capillary volume because the
effective oncotic pressure of the dextran medium exceeded that of
the initial BSA medium. The glomerular volume decrement
averaged —4.2 0.3%, N = 7. In contrast, control glomeruli did
not undergo any volume change under the same conditions.
0aIbumin for glomeruli incubated with anti-Fxla and comple-
ment was estimated from the concentrations of BSA and dextran
that were isotonic to each other. This condition was met by BSA,
37.7 mm Hg and dextran 18.2 mm Hg; 0albmin calculated from
these values was 0.48, albumjn = 0.52.
Increased albumin permeability was also evidenced by the
finding that the volume response of glomeruli incubated with
anti-Fxla IgG and serum to sequential albumin gradients was
diminished compared to either the volume response of control
glomeruli to albumin or dextran gradients or the response of
experimental glomeruli to dextran gradients (Fig. 1 a and b).
Effect of normal serum, anti-FxIA IgG and complement on
albumin permeability
The ratio of volume change in response to albumin gradients of
15 mm Hg (17.5 mm Hg to 2.3 mm Hg) by control and
A'bumin oncotic gradient, mm Hg
Fig. l.A. Volume response of control glomeruli orglomen4i incubated with
anti-FxJA and pooled human serum to oncotic gradients of high molecular
weight dextran. Volume increment was defined as (Vfiflal — Vjnjtjal)/Vfi=L
and the oncotic gradient as (1Tjjtjai — lTfinaI) Volume increment was
directly proportional to the oncotic gradient and volume responses of
control and experimental glomeruli were nearly identical. These findings
support the hypothesis that incubation with anti-Fx1A and complement
did not alter the relative capillary volume or the compliance of glomeruli.
B. Volume response of control glomeruli and of glomeruli incubated with
anti-Fx1A and pooled human serum to oncotic gradients of BSA. Volume
responses of both control and experimental glomeruli to albumin gradi-
ents were directly proportional to the oncotic gradients. Volume response
of experimental glomeruli was markedly diminished compared to that of
control glomeruli, P < 0.05 vs. control. Thus, lb,,mn of glomeruli treated
with anti-Fx1A and complement is markedly diminished.
experimental glomeruli was used to calculate 0aIbumnand perme-
ability for each experimental condition. Incubation of glomeruli in
pooled normal human serum without prior exposure to antibody
resulted in a time dependent decrease in °'albumin and increase in
albumin permeability. Permeability was increased only slightly
after 10 minutes (P = 0.18 0.06, N = 11) but was increased
further after 20 or 30 minutes of incubation with serum (P = 0.40
0.10, N = 8 and 0.54 0.08, N = 16, respectively). Permeability
was not increased by incubation with serum that had been heated
to inactivate complement. Because complement alone produced
significant injury, subsequent studies were done after 10 minutes
of incubation.
Preincubation of glomeruli with anti-Fxla IgG in serum-free
medium did not increase albumin permeability. The effects of
treatment with anti-Fx1A and subsequent incubation with serum
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Fig. 2. Effects of anti-FxJA and complement on albumin permeabilliy of
isolated glomeruli. Control glomeruli were incubated in isolation medium
alone at 37°C for 15 minutes. To test the effect of complement alone,
normal human serum was added during the 15 minute 37°C incubation. To
test the effect of antibody alone, glomeruli were treated with anti-Fx1A
IgG, 4 mg/mI, for 15 minutes at 4°C then incubated at 37°C for 10 minutes
in isolation medium. To test the effect of antibody plus complement,
glomeruli were treated with anti-Fx1A IgG alone for 10 minutes at 4°C
and then incubated in 2% pooled human serum in incubation medium for
10 minutes at 37°C. Results are presented as mean SEM. N is the number
of glomeruli tested.
followed by incubation in serum-free medium did not increase
albumin permeability. Incubation of anti-Fx1A pretreated gb-
meruli in medium containing heat-inactivated serum also had no
effect on permeability (data not shown). In contrast, incubation of
glomeruli pre-treated with anti-Fx1A in medium containing 2%
pooled normal human serum markedly increased permeability.
Serum deficient in either C6 or C7 did not cause an increase in
albumin permeability of antibody pre-treated glomeruli (P =
—0.13 0.15, N = 8 and —0.09 0.12, N = 11, respectively).
When C6 and C7 deficient sera were combined to reconstitute the
complement system, injury identical to that which occurred in
normal serum was observed (P 0.58 0.04, N 13).
Discussion
Our results demonstrate that activation of C5b-9 by deposition
of anti-Fxla antibody in vitro induces an immediate increase in
glomerular permeability to albumin. Since the complement com-
ponents C6 and C7 have no known biologic effects relevant to
glomerular injury other than to support formation of the C5b-9
complex, we interpret the requirements for these precursor
proteins to produce antibody-mediated glomerular injury in this
system as documenting participation of C5b-9 in this process. No
significant change in permeability occurred following incubation
with large amounts of IgG antibody alone or following incubation
of antibody-sensitized glomeruli with heat-inactivated serum de-
void of complement activity. This requirement for C5b-9 to
mediate proteinuria induced by anti-Fxla antibody confirms pre-
vious in vivo studies which have shown that selective C6 depletion
abrogates development of proteinuria four days after antibody
injection in the intact rat [3] and that proteinuria induced by
anti-Fxla IgG in the isolated perfused rat kidney requires C6 and
C8 [61.
The results of our studies also confirm our previous observa-
tions that changes in glomerular volume in response to alterations
in oncotic pressure gradients can be used to quantify the reflection
coefficient for albumin across the glomerular capillary wall [141. A
rigorous demonstration that 0albumin was less than 1.0 in glomeruli
exposed to antibody and complement was derived from the
finding that replacement of albumin medium by dextran medium
of the same oncotic pressure resulted in an immediate loss of
capillary volume. A numerical estimate of 0alhumin and of albumin
permeability was made using the volume responses of normal
glomeruli to albumin or dextran oncotic gradients. Glomeruli
injured by incubation with complement alone or with complement
after pre-incubation with anti-Fxla had volumetric responses to
dextran that were comparable to those of untreated glomeruli.
This finding is consistent with the interpretation that the capillary
volume available for exchange is about the same after antibody
and complement treatment and that the compliance of the
capillary is not markedly altered by these experimental treat-
ments. In contrast, injured glomeruli had a diminished volume
response to albumin gradients compared to either control gbomer-
uli or to responses of injured glomeruli to dextran gradients.
The values for albumin permeability that are reported here are
much higher than those observed in any naturally occurring or
experimentally induced renal disease during in vivo filtration and
correspond to a sieving coefficient of 0.8, a value more than an
order of magnitude larger than that observed in renal injury [14].
This degree of injury would result in the loss of about 3 g of
albumin/mm in a human with a normal GFR. The very high
permeability may occur either because the injury produced in vitro
may far exceed any that occurs in vivo or because the use of
non-perfused and non-filtering glomeruli to define the °albumin
may reveal a mechanism for protein permeability that has not
been previously recognized. The discrepancy between aalhumjfl
derived from in vivo and in vitro studies is only apparent in injured
glomeruli. Further experiments will be required to determine
which of the postulated explanations is correct. In the interim,
however, diminished values of YaIhumin in vitro clearly indicate the
presence of altered macromolecular permeability and provide us
with a means to assess the degree of injury to the capillary
filtration barrier in isolation from other potential mediators of
injury.
An additional finding of some interest in the present study was
that the C5b-9 induced change in albumin permeability in the
isolated glomerulus was present at the earliest time point mea-
sured, 10 minutes after complement exposure. In contrast to the
immediate sublytic effects of C5b-9 on GEC in culture, protein-
uria induced by C5b-9 does not occur for three to four days
following anti-Fxla antibody injection in the intact animal [18]
and for about 20 minutes after initial antibody-complement
exposure in the isolated perfused kidney [6]. This interval between
initial antibody deposition with C5b-9 attack and the development
of detectable functional changes in the permeability barrier has
confused analysis of the relationship between known conse-
quences of C5b-9 attack on the GEC and the development of
proteinuria. Our study indicates that the functional consequences
of C5b-9 attack on the GEC occur almost immediately in this
system with no lag phase involved. Thus the delay in development
of proteinuria in other models probably reflects the length of time
required to deposit a nephritogenic quantity of antibody in the
subepithelial space in the functioning kidney as well as the
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perfused kidney which makes early changes in permeability more
difficult to detect [161.
The nature of the cellular events induced by C5b-9 which lead
to proteinuria have not been addressed by our studies, although
the isolated glomerulus should provide a valuable tool to conduct
such studies. Several possibilities merit consideration. C5b-9
stimulates production of proteases by mesangial cells in culture
[19]. Proteases with GBM degrading properties are also made by
glomerular epithelial cells and are released in increased quantities
by glomeruli of rats with C5b-9 mediated PHN [20]. Similar
proteases can induce increased albumin permeability in isolated
glomeruli in vitro [21]. C5b-9 can also stimulate oxidant produc-
tion by glomerular cells [22]. Increased oxidant production has
been documented in C5b-9 mediated PHN [23], and anti-oxidants
reduced proteinuria in this model [24—26]. Oxidants also increase
glomerular albumin permeability in our system in vitro [27] and
account for the increased permeability induced by TNF which
may be released in response to C5b-9 [28, 29]. Other molecules
released in increased amounts by glomerular cells in response to
C5b-9 such as prostaglandins [28, 30], interleukins 1 and 6 [31],
and extracellular matrix components [32], seem less likely than
oxidants or proteases to mediate the immediate change in gb-
merular albumin permeability induced by C5b-9 in our studies.
The phenomenon of altered glomerular permeability induced
by C5b-9 in normal glomeruli incubated with complement alone
also merits comment. Our previous studies have established that
kidney cells damaged by a variety of mechanisms can serve as
activators of the alternate complement pathway leading to C5b-9
formation [33, 34]. Although isolated glomeruli, as in this study,
appear relatively intact by both structural and functional measures
[10], some damage to the resident epithelial cell layer probably
occurs. Such damaged cells, or cell fragments, may induce local
C5b-9 formation [33, 34]. C5b-9 attack on nearby viable cells
would then occur in quantities that may be sufficient to produce
injury [35]. Our studies provide the first evidence that such C5b-9
formation may be sufficient to induce an abnormality in glomer-
ular function.
In summary, our studies provide evidence for a direct effect of
C5b-9 activated by both antibody deposition and non-immune
processes on the permeability of the normal glomerulus to
albumin. They further establish the utility of the isolated glomer-
ulus as a tool for studying the effects of various immune events on
glomerular permeability to protein and document the feasibility of
this technology for examining the link between cellular events
produced by inflammatory mediators including antibody, comple-
ment and various cytokines and the functional consequences of
these effects which result in disease manifestations such as
proteinuria.
Acknowledgments
This work was supported by US PHS Grants DK 22040 (VJS) and DK
34198 (WGC), George M. O'Brien Kidney Research Center Grant DK
47659 and by grants from the Kansas Aituliate of the American Heart
Association, and from the BRSG at the University of Kansas Medical
Center.
Reprint requests to Virginia J. Savin, M.D., Division of Nephrology, 4015
Sudler, University of Kansas, Medical Center, 39th and Rainbow Blvd,
Kansas City, Kansas 66160-7382, USA.
1. COUSER WG, ABRAss CK: Pathogenesis of niembranous nephropathy.
Annu Rev Med 39:517—530, 1988
2. KERJASCHKI D: Molecular pathogenesis of membranous nephropathy.
Kidney mt 41:1090—1105, 1992
3. BAKER PJ, OcHI RF, SCHULZE M, JOHNSON RJ, CAMPBELL C, COUSER
WG: Depletion of C6 prevents development of proteinuria in exper-
imental membranous nephropathy in rats, Am J Pathol 135:185—194,
1989
4. Cous WG, OcHI RF, BAKER PJ, JOHNSON RJ, SCHULZE M,
CAMPBELL C: Depletion of C6 reduces proteinuria in a model of
membranous nephropathy induced with a non-glomerular antigen. J
Am Soc Nephrol 2:894—901, 1991
5. GROGGEL GC, ADLER S, RENNKE HG, COUSER WG, SALANT DG:
Role of the terminal complement pathway in experimental membra-
nous nephropathy in the rabbit. J Clin Invest 72:1948—1957, 1983
6. CYBULSKY AV, QUIGG RJ, SALANT DJ: The membrane attack com-
plex in complement-mediated glomerular epithelial cell injury: For-
mation and stability of C5b-9 and C5b-7 in rat membranous nephrop-
athy.Jlmmunol 137:1511—1516, 1986
7. QUIGG RJ, CYBULSKY AV, JACOBS JB, SALANT DJ: Anti-Fx1A pro-
duces complement-dependent cytotoxicity of glomerular epithelial
cells. Kidney mt 34:43—52, 1988
8. CYBULSKY AV, SALANT DJ, QUIGG RJ, BADALAMENTI J, BONVENTRE
JV: Complement C5b-9 complex activates phospholipases in glomer-
ular epithelial cells. Am J Physiol 257:F826—F836, 1989
9. CYBULSKY AV, BONVENTRE JV, QuIGG RJ, LIEBERTHAL W, SALANT
DJ: Cytosolic calcium and protein kinase C reduce complement-
mediated glomerular epithelial cell injury. Kidney Int 38:803—811,
1990
10. SAVIN VJ, TERREROS DA: Filtration in single isolated mammalian
glomeruli. Kidney Int 20:188—197, 1981
11. CHANG RS, Uctu IF, TROY JL, DEEN WM, ROBERTSON CR, BRENNER
BM: Permselectivity of the glomerular capillary wall to macromole-
cules. II. Experimental studies in rats using neutral dextran. Biophys J
15:887—906, 1975
12. BERTOLATUS JA, ABUYOUSEF M, HUNSICKER LG: Glomerular sieving
of high molecular weight proteins in proteinuric rats. Kidney Int
31:1257—1266, 1987
13. MYERS BD, OKARMA TB, FRIEDMAN S, BRIDGES CR, Ross J, ASSEFF
S, DEEN WM: Mechanisms of proteinuria in human glomerulus. J Clin
Invest 70:732—746, 1982
14. SAvIN VJ, SHARMA R, LOVELL HB, WELLING DJ: Measurement of
reflection coefficient using isolated rat glomeruli. J Am Soc Nephrol
3:1260—1269, 1992
15. SALANT DJ, DARBY C, COUSER WG: Experimental membranous
glomerulonephritis in rats. Quantitative studies of glomerular immune
deposit formation in isolated glomeruli and whole animals. J Clin
Invest 66:71—81, 1980
16. CouseR WG, DARBY C, SALANT DJ, ADLER S, STEELE KM, STILMANT
MM, LOWENSTEIN LM: Effect of antibody to glomerular basement
membrane on protein excretion in the isolated perfused rat kidney.
Am I Physiol 249:F241—F250, 1985
17. JOHNSON RJ, YAMABE H, Cl-mN Y-P, CAMPBELL C, GORDON K, BAKER
P, LOVETF D, COUSER WG: Glomerular epithelial cells release a
glomerular basement membrane degrading metalloprotease. JAm Soc
Nephro! 2:1388—1397, 1992
18. FLOEGE J, JOHNSON RJ, GORDON K, YOSHIMURA A, CAMPBELL C,
IRUELA-ARISPE L, ALPERS CE, COUSER WG: Altered glomerular
extracellular matrix synthesis and gene expression in experimental
membranous nephropathy: Studies in two models in cultured glomer-
ular epithelial cells. Kidney mt 42:573—585, 1992
19. HANSCH GM, SCHIEREN G, WAGNER C, SCHONERMARK M: Immune
damage to the mesangium: Antibody—and complement—mediated
stimulation and destruction of mesangial cells. J Am Soc Nephrol
2:S139—S143, 1992
20. WATANABE K, KINOSHITA 5, NAKAGAWA H: Gelatinase secretion by
glomerular epithelial cells. Nephron 56:405—409, 1990
21. SAvIN VJ, SHARMA R, Suzun K, NAGASE H: Matrix metalloprotein-
ase-3 (stromelysin) increases albumin permeability of isolated rat
glomeruli. (abstract) Clin Res 39:308A, 1991
References
Savin et at: C5b-9 in isolated glomendi 387
22. ADLER S, BAKER PJ, JOHNSON RJ, Oct-u RF, PRITZL P, COUSER WG:
Complement membrane attack complex stimulates production of
reactive oxygen metabolites by cultured rat mesangial cells. J Gun
Invest 77:762—767, 1986
23. NEALE TJ, ULLRICH R, On-IA P, PoczEwsKl H, VERHOEVEN AJ,
KERJASCHKI D: Expression of a neutrophil respiratoly burst cyto-
chrome and reactive oxygen species in kidney glomeruli: Association
with proteinuria in passive Heymann nephritis. Proc Nati Acad Sci
USA 90:3645—3649, 1993
24. LOTAN D, KAPLAN BS, FONG JSC, GOODYER PR, DECHADAREVIAN
J-P: Reduction of protein excretion by dimethyl sulfoxide in rats with
passive Heymann nephritis. Kidney mt 25:778—788, 1984
25. KAPLAN BS, MILNER LS, LOTAN D, MILLS M, GOODYER PR, FONG
JSC: Interaction of dimethyl sulfoxide and nonsteroidal anti-inflam-
matory agents in passive Heymann's nephritis. J Lab Clin Med
107:425—430, 1986
26. SHAH SV: Evidence suggesting a role for hydroxyl radical in passive
Heymann nephritis in rats. Am J Physiol 254:F337—F344, 1988
27. DILEEPAN KN, SHARMA R, STECHSCHULTE D, SAVIN VJ: Effect of
superoxide exposure on albumin permeability of isolated rat glomer-
uli.JLab Clin Med 121:797—804, 1993
28. HANSCH GM, BETZ M, GUNTHER J, ROTHER KO, STERZEL B: The
complement membrane attack complex stimulates the prostanoid
production of cultured glomerular epithelial cells. Int Arch Allergy
Appi Immunol 85:87—93, 1988
29. MCCARTHY ET, SHARMA R, Li J-Z, SAVIN VJ: TNF-cr increases
albumin permeability through the generation of superoxide (abstract)
JAm Soc Nephrol 4:620, 1993
30. STAHL RAK, ADLER S, BAKER PJ, CHEN Y-P, PRITZL PM, COUSER
WG: Enhanced glomerular prostaglandin formation in experimental
membranous nephropathy. Kidney mt 31:1126—1131, 1987
31. SCI-IONERMARK M, DEPPISCH R, RIEDASCH G, ROTHER K, HANSCH
GM: Induction of mediator release from human glomerular mesangial
cells by the terminal complement components C5b-9. mt Arch Allergy
Appl Immunol 96:331—337, 1991
32. TORBOHM I, SCHONERMARK M, WINGEN AM, BERGER B, ROTHER K,
HANSCH GM: C5b-8 and C5b-9 modulate the collagen release of
human glomerular epithelial cells. Kidney mt 37:1098—1104, 1990
33. BAKER PJ, OSOFSKY SG: Activation of human complement by heat-
killed, human kidney cells grown in cell culture.Jlmmunol 124:81—91,
1980
34. BAKER PJ, ADLER S, YG Y, CaUSER WG: Complement activation
by heat-killed human kidney cells: Formation, activity and stabiliza-
tion of cell-bound C3 convertases. J Immunol 133:877—881, 1984
35. GOTZE 0, MULLER-EBERHARD HJ: Lysis of eiythrocytes by comple-
ment in the absence of antibody. JExp Med 132:898—911, 1970
